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Using the monoclonal antibody 1<,8 .12 directed against ker-
atins 13 and 16, we have studied psoriatic and trauma-in-
duced hyperproliferacion. In normal skin 40 and 64 h after 
selIotape stripping and in psoriatic lesions, a pronounced su-
prabasal staining by 1<,8. 12 was observed. In unstrirped nor-
mal skin and in the clinically uninvolved skin 0 psoriatic 
Keratinocytes in culture arc characterized by the ap-pearance of low molecular weight keratins, including a 48 kD keratin (keratin 16). These keratins are also expressed in the lesional epidermis of psoriasis [1]. Of special incerest is keratin 16. First, rhis keratin is ex-
pressed exclusively in hyperproliferative skin disorders such as pso-
riasis and squamous cell carcinomas and it has been reported to be 
absent in normal skin [1.2]. Second, the reduction of this particular 
keratin has been claimed as the most reliable marker of clinical 
resolution of the psoriatic lesion [3]. 
To characterize the keratins in psoriasis. Sun et 31 have carried out 
elaborate investigations combining immunohistochemical staining 
with tile monoclonal antibody AE1, which recognizes the acidic 
subfamily of keratins [4], including keratin 16, and SDS polyacryl-
amide gel electrophoresis [1,5]. These studies showed that this kera-
tin, among others, is expressed in the suprabasal layers of lesional 
epidermis and in regenerating efidermis of healthy comrols. 
Recendy, a new monoclona antibody reactive with keratins 
(K,B.12) has been characterized by Huszar et al [6]. The immuno-
blotting analysis showed a specific binding of this antibody to kera-
tins 13 and 16. A minor extra spot in the region of keratin 15 was 
only seen in an epidermal carcinoma cel l line. Neither normal nor 
diseased epidermis contain keratin 13 (6,7]. Keratin 15 is expressed 
by basal cells of normal human epidermis in minor amounts [7]; 
therefore, K,B.12 may he regarded as specific for keratin 16 in the 
suprabasallayers of the skin. In this paper we report the distribution 
and degree of expression of keratin 16 in lesional and clinically 
uninvolved skin of psoriatic patients and in regenerating epidermis 
of healthy volunteers as detected by this monoclonal antibody. 
MATERIALS AND METHODS 
SkiD Sam pling Razor-blade biopsies {5 mm diameter, 0.3 mOl 
thickness} were taken from the normal skin of eight healthy vol un-
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pacients some pacchy staining limiced co che basal layer was 
seen . The clear distinction between normal and hyperprolif-
erative skin in keratin expression as detected by ~8.12 indi-
cates thac chis antibody may serve as a marker for epidermal 
proliferation in psoriasis.] Invest DermatoI92:130 - 131} 1989 
teers and from the lesional and clinically uninvolved skin of four 
patients with stable chronic plaque psoriasis. Further biopsies were 
raken from sellotape-stripped sites [B] on tv.'o subjects at 40 and 64 h 
after stripping; these times were selected because regeneration is 
iniriared about 40 h after injury and is well-established at 64 h [9]. 
Immunohistochemical Staining All biopsies were frozen im-
mediately in Tissue-Tek JI OCT compound (Miles Scientific, Na-
perville, U.S.A.) and sectioned at B Jim. After fixation with ace-
tone·ether (60/40 v/v), the frozen sections were washed in 
phosphore-buffered saline (PBS) containing 0.01 % Tween 80. 
Slides were incubated for 30 min at room temperature with K.B. 12 
(Bio-Veda, Rehovor, Israel) dilured 1 :40 in PBS. After 3 washes 
with PBS the slides were incubated for 30 min at room temperature 
with peroxidase-col~ugated rabbit anti-mouse inullunoglobulins 
(DAKOPA TIS, Copenhagen, Denmark) diluted I : 25 in PBS con-
taining 5% human AB·serum. After three further washes with PBS 
and a preincubation with sodium acetate buffer (PH 4. 9), sl ides were 
finally stained in sodium acetate buffer containing 200 mgjl 3-
amino-9-ethyl-carbazole solution and 350 ,ulfl 30% HzOz (pre-
pared freshly) for 10 min at room temperature in the dark. 
After two washes with demineralized water, slides were counter-
stained with haematoxylin (Mayer) and mounted in glycerin gela-
tin. The slides were studied using a Leitz Laborlux 12 light micro-
scope. 
RESULTS 
K.B.12 staining of normal skin was patchy with a sharp demarcation 
between positive and ncgative areas. The percentage of cells stain-
ing varied between healthy volunteers. but was minimal and always 
restricted to dceper rete ridges of the basal layer. Figure 1 demon-
strates an example representative of all the healthy volunteers. The 
clinically uninvolved skin of psoriatic patiencs showed an essentially 
similar pattern to that observed in healthy volunteers. 
In contrast, the lesional skin of all patiencs showed a positive 
Ks8.12 staining of the lluprabasal layers, which was more pro-
nounced and uniformly distribuced. In Fig 2 these characteristics 
can be seen. This difference between lesiona! skin [4] and clinically 
uninvolved skin (four patients and eight healthy controls) was 
clearly evident. Statistical analysis (two-tailed Wilcoxon ranking 
test) revealed a highly significant difference (P < 0.01). 
I(.B.12 staining in tape stripped skin of normal volunteers showed 
a pattern resembling the distribution in lesional skin of psoriatic 
patients. In all biopsies, 40 h after tape-stripping K,8 .12 binding 
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Figure 1. K.8.12 stOlining of normal skin (X50). Bar: tOO/lm. 
was in the suprabasal layers but was less uniformly distributed and 
less marked than that secn in the psoriatic lesion (Fig 3). After 64 h 
the suptabasal staining showed within the same section a wide varia-
tion in intensity. In addition, basal stain.ing was seen in all biopsies of 
stripped skin, showing rhe same patchy distribution as their un-
stripped equivalents. No sharp demarcation was seen berween su-
prabasal scaining and the relatively inconspicious basal staining. The 
frontier of K,8.12 staining at 40 h after stripping was located at the 
top of the stratum spinosum and by 64 h had advanced to the stra-
tum corneum conjunctum. 
DISCUSSION 
In the psoriatic lesion a subfamily of acidic kerarins, confined to the 
basal layer of normal skin [5], is expressed in the suprabasal cell 
layers. One of the most important of these keratins is keratin 16. In 
the present study we visualized this characteristic change in the 
expression of keratin 16 in hyperproliferative epidermis. 
This investigation demonstrates that the immunohistochemical 
use of K,8. 12 permits a reliable distinction between the hyperproli-
ferative epidermis of the psoriatic lesion or regenerating skin and 
the epidermis of normal skin. In the psoriatic lesion keratin 16 is 
expressed in the whole suprabasaJ compartment except the stratum 
corneum. Because cycling cells do not occur in the upper part of the 
stratum spinosul1l (Van Erp et ai, unpublished) , the expression of 
keratin 16 seems morc likely a consequence of hyperproliferarion 
than a cause. 
In normal skin no K.8.12 staining has been observed in the supra-
basal ceHlayers. A minor and variable staining was seen in the basal 
layer of these sections. Although keratin 16 is supposed to occur 
exclusively in the suprabasal layers [to] of hyperproliferative epi-
dermis and to be absent in normal skin [1,21. Kim et al reported that 
this keratin is expressed in basal cells of cultured human epidermis 
(11]. If we assume that this patchy staining is due to keratin 16 
expression in the deeper rete ridges, then this observation supports 
the contention of Lavkcr and Sun that the basal cells in these loca-
tions are hyperproliferative compared to basal cells elsewhere [12]. 
Perhaps a less controversial explanation for the basal staining in the 
present study is cross-reactivity with keratin 15 [2,6,7]' 
Figure 2. K,8. 12 staining of psoriatic lesion (X t 90). Bar: 100,um. 
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Figure 3. K,8.12 staining of normal skin 40 h after sellotape stripping 
(X80) . B,,: l00pm. 
The heterogeneity of the staining intensity in rhe biopsies 40 and 
64 h after stripping is a remarkable finding. This pattern suggesrs a 
variation in expression of keratin 16 during the process of epidermal 
recovery following injury. It has been shown chat a synchronized 
cohort of cells enters the cycle at about 40 h afrer stripping. and it is 
possible that changes in keratin 16 expression are related to the 
subsequent progress of this cohorr rhrough the cycle. Further S[ud-
ies are necessary to test this hypothesis. 
The simplicity of the method makes it very attracrive for studies 
on proliferation in skin. The srriking difference between normal 
and lesional skin of psoriasis in terms of 1<..8.12 staining makes it a 
very interesring parameter for studies on this disease. 
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